A Real-World Evidence in Understanding the Barriers and Behaviours of Insulin Therapy among Indian Type 2 Diabetes Mellitus (T2DM) Patients

被引：0

|

作者：

Raj, Praveen

Pawar, Dilip

Jabeen, Sarah

Shivaram, V. S.

机构：

来源：

DIABETES | 2018年 / 67卷

关键词：

D O I：

10.2337/db18-884-P

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页数：2

相关论文

共 50 条

[1] Real-World Study of Delayed Initiation of Insulin and Associated Factors Among Elderly Patients With Type 2 Diabetes Mellitus (T2DM)
Bhattacharya, Rituparna
Zhou, Steve
Wei, Wenhui
Ajmera, Mayank
Ling, John
Sambamoorthi, Usha
[J]. DIABETES, 2013, 62 : A323 - A323
[2] Adherence to Insulin Therapy Assistance Program (iTAP) among Indian Type 2 Diabetes Mellitus (T2DM) Patients
Raj, Praveen
Pawar, Dilip
Jabeen, Sarah
Shivaram, V. S.
[J]. DIABETES, 2018, 67
[3] Promoters of and Barriers to Engagement in Type 2 Diabetes Mellitus (T2DM) Populations with Real-World Technological Interventions
Duvall, Kevin R.
Trasy, Anjali
Murray, Erin
Milam, Robert
Sayre, Tobias
Beal, Anne C.
[J]. DIABETES, 2018, 67
[4] Association of Treatment Persistence and Adherence With Real-World Outcomes Among Insulin-Treated Patients With Type 2 Diabetes Mellitus (T2DM)
Wei, Wenhui
Pan, Chunshen
Xie, Lin
Baser, Onur
[J]. DIABETES, 2012, 61 : A4 - A4
[5] REAL-WORLD INCIDENCE OF HYPOGLYCEMIA AND ASSOCIATED COSTS AMONG INSULIN GLARGINE-TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
Xie, L.
Wei, W.
Pan, C.
Baser, O.
[J]. VALUE IN HEALTH, 2012, 15 (07) : A493 - A493
[6] Real-World Treatment for Diabetic Nephropathy (DN) in Patients with Type 2 Diabetes Mellitus (T2DM)
Chaudhari, Paresh
Zhou, Zhou
Yang, Hongbo
Zhao, Jing
Wu, Eric
Seifeldin, Raafat
[J]. DIABETES, 2016, 65 : A603 - A603
[7] Real-world treatment switching patterns in patients (pts) with type 2 diabetes mellitus (T2DM) on basal insulin (INS)
Kapustin, J.
Anderson, J. E.
Reid, T.
Rhinehart, A.
Brunton, S.
Stewart, J.
Zhou, W.
Dex, T.
Kazemi, M.
Vlajnic, A.
Dalal, M.
[J]. DIABETOLOGIA, 2014, 57 : S440 - S440
[8] Effects of Insulin Adherence and Delivery Device on Real World Outcomes Among Patients With Type 2 Diabetes Mellitus (T2DM)
Ayyagari, Rajeev
Wei, Wenhui
Cheng, David
Pan, Chunshen
Wu, Eric Q.
[J]. DIABETES, 2013, 62 : A327 - A327
[9] Remogliflozin in Indian T2DM Patients: A Real-World Study
Bhattacharya, Supratik
Katare, Sagar
[J]. DIABETES, 2020, 69
[10] Real-World (RW) Glycemic Control and Medication Adherence among Patients with Type 2 Diabetes Mellitus (T2DM) Initiated on Canagliflozin
Jain, Rahul
Cai, Jennifer
Fu, An-Chen
Chow, Wing
Tan, Hiangkiat
[J]. DIABETES, 2016, 65 : A304 - A305

← 1 2 3 4 5 →